<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>r36200def14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>



<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>SCHEDULE
14A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Filed by the Registrant</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings"><B>x</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">Filed by a Party other than the Registrant</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: justify">Check the appropriate box:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Preliminary Proxy Statement</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>Confidential, For Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">x</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Definitive Proxy Statement</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Definitive Additional Materials</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Soliciting Material Pursuant to &sect; 240.14a-12</TD></TR>
<TR>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 59%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 24pt"><B><U>DPW
HOLDINGS, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified in its
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Payment of Filing Fee (Check the appropriate box):</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Wingdings"><B>x</B></FONT></TD>
    <TD STYLE="width: 99%">No fee required</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD>Fee computed on table below per Exchange Act Rules 14a-6(i) (1) and 0-11.&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%">(1)</TD>
    <TD STYLE="width: 97%; border-bottom: black 1.5pt solid; text-align: justify">Title of each class of securities to which transaction applies: </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(2)</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">Aggregate number of securities to which transaction applies: </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(3)</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(4)</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">Proposed maximum aggregate value of transaction: </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(5)</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">Total fee paid: </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Wingdings">&uml;</FONT>&nbsp;</TD>
    <TD STYLE="width: 99%">Fee paid previously with preliminary materials:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD>Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 1%">(1)</TD>
    <TD STYLE="width: 98%; text-align: justify">Amount Previously Paid: </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(2)</TD>
    <TD STYLE="text-align: justify">Form, Schedule or Registration Statement No.: </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(3)</TD>
    <TD STYLE="text-align: justify">Filing Party: </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>(4)</TD>
    <TD STYLE="text-align: justify">Date Filed: </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->





<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFINITIVE PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DPW HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>201 Shipyard Way, Suite E</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Newport Beach, California 92663</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Telephone:&nbsp;(949) 444-5464</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF SPECIAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>To Be Held on March 31, 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cordially invite
you to attend the Special Meeting of Stockholders of DPW Holdings, Inc. (&ldquo;<B>DPW</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;).
Our Special Meeting will be held on March 31, 2020 at 9:00 a.m. PT at the Hyatt Regency Hotel Newport Beach, located at 1107 Jamboree
Road, Newport Beach, CA 92660. You will be able to attend the Special Meeting and vote by visiting www.proxyvote.com if you are
a beneficial owner and at www.investorvote.com/DPW if you are a registered holder. To enter the meeting, you must have your control
number that is shown on the proxy card accompanying this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Details regarding logging
onto and attending the meeting over the website and the business to be conducted are described in the Proxy Card included with
this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Special Meeting
will be held for the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To approve, pursuant to Rule 713 of the NYSE American, the issuance of shares of the Corporation&rsquo;s
Class A common stock, par value $0.001 per share (&ldquo;<B>Common Stock</B>&rdquo;) to Esousa Holdings LLC (&ldquo;<B>Esousa</B>&rdquo;),
in accordance with the Master Exchange Agreement dated February 10, 2020, and the exercise of warrants issued in connection therewith;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To approve the exercise of warrants issued or issuable to Esousa to purchase up to an aggregate
of 2,000,000 shares of Common Stock, issued in connection with certain term promissory notes in an aggregate amount of up to $2,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To approve the conversion of&nbsp;a $1,000,000 Convertible Promissory Note issued on February 5,
2020 (the &ldquo;<B>Ault Note</B>&rdquo;), to Ault &amp; Company, Inc., which is convertible into 717,241 shares of Common Stock
at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of August 5, 2020, the maturity
date of the Ault Note), in order to comply with the listing rules the NYSE American; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The transaction of such other business as may properly come before the Special Meeting or any adjournments
or postponements thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying proxy
statement sets forth additional information regarding the Special Meeting, and provides you with detailed information regarding
the business to be considered at the Special Meeting. We encourage you to read the proxy statement carefully and in its entirety.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only stockholders of
record at the close of business on March 2, 2020, the record date for the Special Meeting, will be entitled to attend and vote
at the Special Meeting or any adjournments or postponements thereof. The proxy materials will be mailed to stockholders on or about
March 12, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Important Notice
Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be held on March 31, 2020:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This Notice of Special Meeting of Stockholders
and the accompanying Proxy Statement are available</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>on the Internet at www.envisionreports.com/DPW.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BY ORDER OF THE BOARD OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Milton C. Ault III</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer and Chairman of the Board</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 11, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><U>HOW TO VOTE</U>:
Your vote is important. Whether or not you plan to attend the Special Meeting, we hope you will vote as soon as possible by either
(1) mailing your completed and signed proxy card(s) to DPW Holdings, Inc., 201 Shipyard Way, Newport Beach, CA 92663, Attention:
Corporate Secretary, (2) calling the toll-free number printed on your proxy card(s) and following the recorded instructions or
(3) visiting the website indicated on your proxy card(s) and following the on-line instructions. You may revoke a previously submitted
proxy at any time prior to the Special Meeting. If you decide to attend the Special Meeting and wish to change your proxy vote,
you may do so automatically by voting in person at the Special Meeting.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 95%; border-bottom: #4BACC6 1pt solid; text-align: center"><B>TABLE OF CONTENTS</B></TD>
    <TD STYLE="vertical-align: bottom; width: 5%; border-bottom: #4BACC6 1pt solid; text-align: center">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: #4BACC6 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #4BACC6 1pt solid; text-align: center"><B>Page</B></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>INFORMATION CONCERNING THE SPECIAL MEETING</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">1</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">3</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PROPOSAL NO. 1: APPROVAL, PURSUANT TO
        NYSE AMERICAN LISTING RULE 713, OF THE ISSUANCE OF</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SHARES OF OUR COMMON STOCK TO ESOUSA</B></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">8</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Overview of Exchange Agreement</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">8</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Stockholder Approval Requirement</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">9</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Reasons for Transaction</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">10</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Effect on Current Stockholders; Dilution</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">10</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><B>Required Vote and Board Recommendation</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">10</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>PROPOSAL NO. 2: APPROVAL OF THE EXERCISE OF WARRANTS TO PURCHASE UP TO 2,000,000 SHARES <BR>
OF COMMON STOCK IN ORDER TO&nbsp;COMPLY WITH&nbsp;RULE 713 OF THE NYSE AMERICAN</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">11</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Terms of the Transaction</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">11</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Description of the Warrants</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">11</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Why the Company Needs Stockholder Approval</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">11</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Effect of Proposal on Current Stockholders</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">11</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Required Vote and Board Recommendation</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">11</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PROPOSAL NO. 3: APPROVAL OF THE CONVERSION
        OF A $1,000,000 CONVERTIBLE PROMISSORY NOTE<BR>
        INTO 717,241 SHARES OF COMMON STOCK IN ORDER TO&nbsp;COMPLY WITH&nbsp;RULE 713 OF THE NYSE</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>AMERICAN</B></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">12</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Terms of the Transaction</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">12</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Why the Company Needs Stockholder Approval</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">12</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Effect of Proposal on Current Stockholders</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">12</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Further Information</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">12</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>Required Vote and Board Recommendation</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">12</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: justify"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">13</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; text-align: justify"><B>OTHER BUSINESS</B></TD>
    <TD STYLE="vertical-align: bottom; text-align: right">14</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DPW HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>201 Shipyard Way, Suite E</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Newport Beach, California 92663</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Telephone:&nbsp;(949) 444-5464</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEFINITIVE PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE SPECIAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE HELD ON MARCH 31, 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION CONCERNING THE SPECIAL MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The enclosed proxy
is solicited by the Board of Directors (the &ldquo;<B>Board</B>&rdquo;) of DPW Holdings, Inc. (the &ldquo;<B>Company</B>&rdquo;
or &ldquo;<B>DPW</B>&rdquo;), for use at a Special Meeting of the Company&rsquo;s stockholders (the &ldquo;<B>Special Meeting</B>&rdquo;)
to be held on March 31, 2020 at 9:00 PT at the Hyatt Regency Hotel Newport Beach, located at 1107 Jamboree Road, Newport Beach,
CA 92660 and at any adjournments thereof. Whether or not you expect to attend the Special Meeting in person, please vote your shares
as promptly as possible to ensure that your vote is counted. The proxy materials will be furnished to stockholders on or about
March 12, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Action to be taken under Proxy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise directed
by the giver of the proxy, the persons named in the form of proxy, namely, Milton C. &ldquo;Todd&rdquo; Ault, III, the Company&rsquo;s
Chairman and Chief Executive Officer, and William B. Horne, the Company&rsquo;s Chief Financial Officer, or either one of them
who acts, will vote:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">FOR approval, pursuant to Rule 713 of the NYSE American, of the issuance of shares of the Corporation&rsquo;s
Class A common stock, par value $0.001 per share (&ldquo;<B>Common Stock</B>&rdquo;) to Esousa Holdings LLC (&ldquo;<B>Esousa</B>&rdquo;),
in accordance with the Master Exchange Agreement dated February 10, 2020, and the exercise of warrants issued in connection therewith;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">FOR approval of the exercise of warrants issued or issuable to Esousa to purchase up to an aggregate
of 2,000,000 shares of Common Stock, issued in connection with certain term promissory notes in an aggregate amount of up to $2,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">FOR approval of approve the conversion of&nbsp;a $1,000,000 Convertible Promissory Note issued
on February 5, 2020 (the &ldquo;<B>Ault Note</B>&rdquo;), to Ault &amp; Company, Inc., which is convertible into 717,241 shares
of Common Stock at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of August
5, 2020, the maturity date of the Ault Note), in order to comply with the listing rules the NYSE American; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">In their discretion, on the transaction of such other matters as may properly come before the meeting
or any adjournment thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By submitting your
proxy (via the Internet, telephone or mail), you authorize Milton C. &ldquo;Todd&rdquo; Ault, III, the Company&rsquo;s Chairman
and Chief Executive Officer, and William B. Horne, the Company&rsquo;s Chief Financial Officer, to represent you and vote your
shares at the Special Meeting in accordance with your instructions. They also may vote your shares to adjourn the Special Meeting
and will be authorized to vote your shares at any postponements or adjournments of the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>YOUR VOTE IS IMPORTANT.
WHETHER OR NOT YOU PLAN TO ATTEND THE SPECIAL MEETING, PLEASE PROMPTLY VOTE YOUR SHARES OVER THE INTERNET, BY TELEPHONE OR BY MAIL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Who is Entitled to Vote; Vote Required;
Quorum</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the record date
of March 2, 2020 (the &ldquo;<B>Record Date</B>&rdquo;), there were 4,943,649 shares of Common Stock issued and outstanding; 7,040
shares of Series A Cumulative Redeemable Perpetual Preferred Stock issued and outstanding and 125,000 shares of Series B Convertible
Preferred Stock issued and outstanding, which constitute all of the outstanding capital stock of the Company. Stockholders are
entitled to one vote for each share of Common Stock held by them. The 125,000 shares of Series B Convertible Preferred Stock carry
the voting power of&nbsp;0.05% of all votes entitled to be voted at the Special Meeting. The up to 10,000,000 shares of common
stock issuable upon exercise of warrants issuable to Esousa will, assuming (i) approval of Proposal 2 and the (ii) the issuance
of promissory notes in an aggregate amount of $2,000,000, carry the voting power of a presently indeterminate percentage of all
votes entitled to be voted at any annual or special meeting of stockholders of our Company or action by written consent of our
stockholders but will not carry any voting rights at the Special Meeting. The up to 717,241 shares of common stock issuable upon
conversion of the note issued to Ault &amp; Company (the &ldquo;<B>Ault Note</B>&rdquo;) will, assuming approval of Proposal 3,
carry the voting power of 12.67% of all votes entitled to be voted at any annual or special meeting of stockholders of our Company
or action by written consent of our stockholders but will not carry any voting rights at the Special Meeting; the figure 717,241
assumes the Ault Note will be converted at maturity, when its principal and interest will amount to $1,040,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A majority of the 4,943,649
outstanding shares of Common Stock will constitute a quorum at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brokers holding shares
of record for customers generally are not entitled to vote on &ldquo;non-routine&rdquo; matters, unless they receive voting instructions
from their customers. As used herein, &ldquo;uninstructed shares&rdquo; means shares held by a broker who has not received such
instructions from its customers on a proposal. A &ldquo;broker non-vote&rdquo; occurs when a nominee holding uninstructed shares
for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with
respect to that non-routine matter. In connection with the treatment of abstentions and broker non-votes, all of the proposals
at this Special Meeting are considered &ldquo;non-routine&rdquo; matters, and brokers are not entitled to vote uninstructed shares
with respect to the proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Determination of whether
a matter specified in the Notice of Special Meeting of Stockholders has been approved will be determined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">For each matter specified in the Notice of Special Meeting of Stockholders, the affirmative vote
of a majority of the shares of Common Stock present at the meeting in person or by proxy and entitled to vote on such matter is
required for approval. Abstentions will be considered shares present by proxy and entitled to vote and, therefore, will have the
effect of a vote against the matter. Broker non-votes will be considered shares not present for this purpose and will have no effect
on the outcome of the vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Abstentions and broker
non-votes will be counted for purposes of determining whether a quorum is present for the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>QUESTIONS AND ANSWERS ABOUT THESE PROXY
MATERIALS AND VOTING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>What is the purpose of the Special Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Special Meeting, the stockholders
will be asked:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">To approve, pursuant to Rule 713 of the NYSE American, the issuance of shares of the Corporation&rsquo;s
Class A common stock, par value $0.001 per share (&ldquo;<B>Common Stock</B>&rdquo;) to Esousa Holdings LLC (&ldquo;<B>Esousa</B>&rdquo;),
in accordance with the Master Exchange Agreement dated February 10, 2020, and the exercise of warrants issued in connection therewith;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">To approve the exercise of warrants issued or issuable to Esousa to purchase up to an aggregate
of 2,000,000 shares of Common Stock, issued in connection with certain term promissory notes in an aggregate amount of up to $2,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">To approve the conversion of&nbsp;a $1,000,000 Convertible Promissory Note issued on February 5,
2020 (the &ldquo;<B>Ault Note</B>&rdquo;), to Ault &amp; Company, Inc., which is convertible into 717,241 shares of Common Stock
at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of August 5, 2020, the maturity
date of the Ault Note), in order to comply with the listing rules the NYSE American; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">The transaction of such other business as may properly come before the Special Meeting or any adjournments
or postponements thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Who is entitled to vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Record Date for the Special Meeting
is March 2, 2020. Only stockholders of record at the close of business on that date are entitled to vote at the Special Meeting.
The only class of stock entitled to be voted at the meeting is our Common Stock and Series B Convertible Preferred Stock. On the
Record Date, there were 4,943,649 shares of Common Stock outstanding; and 125,000 shares of Series B Convertible Preferred Stock
issued and outstanding and entitled to vote. The issued and outstanding shares of Series B Convertible Preferred Stock carry the
voting power of 0.05% shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Why am I receiving these materials?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have sent you these proxy materials
because the Board of the Company is soliciting your proxy to vote at the Special Meeting. According to our records, you were a
stockholder of the Company as of the end of business on March 2, 2020, the Record Date for the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You are invited to vote on the proposals
described in this proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to mail these proxy
materials on or about March 12, 2020 to all stockholders of record on the Record Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is included in these materials?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These materials include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the Notice of Special Meeting of Stockholders; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">this Proxy Statement for the Special Meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What is the proxy card?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proxy card enables you to appoint Milton
C. &ldquo;Todd&rdquo; Ault, III, the Company&rsquo;s Chairman and Chief Executive Officer, and William B. Horne, the Company&rsquo;s
Chief Financial Officer, as your representative at the Special Meeting. By completing and returning a proxy card, you are authorizing
these individuals to vote your shares at the Special Meeting in accordance with your instructions on the proxy card. This way,
your shares will be voted whether or not you log in to the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Can I view these proxy materials over
the Internet?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. The Notice of Special Meeting, this
Proxy Statement and accompanying proxy card, and the other documents appended hereto are available at www.envisionreports.com/DPW.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How do I vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Either (1) mail your completed and signed
proxy card(s) to DPW Holdings, Inc., 201 Shipyard Way, Newport Beach, CA 92663, Attention: Corporate Secretary, (2) call the toll-free
number printed on your proxy card(s) and follow the recorded instructions or (3) visit the website indicated on your proxy card(s)
and follow the on-line instructions. If you are a registered stockholder and attend the Special Meeting, then you may deliver your
completed proxy card(s) or vote in person. If your shares are held by your broker or bank, in &ldquo;street name&rdquo;, then you
will receive a form from your broker or bank seeking instructions as to how your shares should be voted. If you do not instruct
your broker or bank how to vote, then your broker or bank will vote your shares if it has discretionary power to vote on a particular
matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Am I entitled to vote if my shares are held in &ldquo;street
name&rdquo;?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are held by a bank, brokerage
firm or other nominee, you are considered the &ldquo;beneficial owner&rdquo; of shares held in &ldquo;street name.&rdquo; If your
shares are held in street name, the proxy materials are being made available to you by your bank, brokerage firm or other nominee
(the &ldquo;<B>record holder</B>&rdquo;), along with voting instructions. As the beneficial owner, you have the right to direct
your record holder how to vote your shares, and the record holder is required to vote your shares in accordance with your instructions.
If you do not give instructions to your record holder, it will not be entitled to vote your shares in its discretion on any proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the beneficial owner of shares, you
are invited to attend the Special Meeting. If you are a beneficial owner, however, you may not vote your shares at the Special
Meeting unless you obtain a legal proxy, executed in your favor, from the record holder of your shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will be able to attend the Special
Meeting, vote, and submit your questions during the meeting via live webcast by visiting www.proxyvote.com if you are a beneficial
owner and hold your shares in &ldquo;street&rdquo; name and at www.investorvote.com/DPW if you are a registered holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>How many shares must be present to hold the Special Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A quorum must be present at the Special
Meeting for any business to be conducted. The presence at the Special Meeting, in person or by proxy, of the holders of a majority
of the shares of Common Stock outstanding on the Record Date will constitute a quorum. Proxies received but marked as abstentions
or treated as broker non-votes will be included in the calculation of the number of shares considered to be present at the Special
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What if a quorum is not present at the
Special Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a quorum is not present or represented
at the Special Meeting, the holders of a majority of the shares entitled to vote at the Special Meeting who are present in person
or represented by proxy, or the chairman of the meeting, may adjourn the Special Meeting until a quorum is present or represented.
The time and place of the adjourned meeting will be announced at the time the adjournment is taken, and no other notice will be
given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Is there a deadline for submitting proxies
electronically or by telephone or mail?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Proxies submitted electronically or by
telephone as described above must be received by 11:59 pm PT on March 30, 2020. Proxies submitted by mail should be received before
9:00 a.m. PT on March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Can I revoke my proxy and change my
vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may change your vote at any time prior
to the taking of the vote at the meeting. If you are the stockholder of record, you may change your vote by (1) granting a new
proxy bearing a later date (which automatically revokes the earlier proxy) using any of the methods described above (and until
the applicable deadline for each method), (2) providing a written notice of revocation to the Company&rsquo;s CEO at DPW Holdings,
Inc., 201 Shipyard Way, Newport Beach, CA 92663, prior to your shares being voted, or (3) attending the Special Meeting and voting.
Attendance at the Special Meeting will not cause your previously granted proxy to be revoked unless you specifically so request.
For shares you hold beneficially in street name, you may change your vote by submitting new voting instructions to your broker,
bank, trustee or nominee following the instructions they provided, or, if you have obtained a legal proxy from your broker, bank,
trustee or nominee giving you the right to vote your shares, by attending the Special Meeting and voting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Who can participate in the Special Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Only stockholders eligible to vote or their
authorized representatives in possession of a valid control number will be admitted as participants to the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Will my vote be kept confidential?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, your vote will be kept confidential
and not disclosed to the Company unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>required by law;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>you expressly request disclosure on your proxy; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&bull;</TD><TD>there is a proxy contest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>How does the Board of Directors recommend I vote on the proposals?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board recommends that you vote your
shares as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B>FOR</B>&rdquo; approval, pursuant to Rule 713 of the NYSE American, of the issuance of
shares of the Corporation&rsquo;s Class A common stock, par value $0.001 per share (&ldquo;<B>Common Stock</B>&rdquo;) to Esousa
Holdings LLC (&ldquo;<B>Esousa</B>&rdquo;), in accordance with the Master Exchange Agreement dated February 10, 2020, and the exercise
of warrants issued in connection therewith;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B>FOR</B>&rdquo; approval of the exercise of warrants issued or issuable to Esousa to purchase
up to an aggregate of 2,000,000 shares of Common Stock, issued in connection with certain term promissory notes in an aggregate
amount of up to $2,000,000; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">&ldquo;<B>FOR</B>&rdquo; approval of approve the conversion of&nbsp;a $1,000,000 Convertible Promissory
Note issued on February 5, 2020 (the &ldquo;<B>Ault Note</B>&rdquo;), to Ault &amp; Company, Inc., which is convertible into 717,241
shares of Common Stock at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of
August 5, 2020, the maturity date of the Ault Note), in order to comply with the listing rules the NYSE American.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless you provide other instructions on
your proxy card, the persons named as proxy holders on the proxy card will vote in accordance with the recommendations of the Board
as set forth in this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>What if I do not specify how my shares are to be voted?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you return a signed and dated proxy
card without marking any voting selections, your shares will be voted in accordance with the Board&rsquo;s recommended votes set
forth immediately above, and if any other matter is properly presented at the Special Meeting, your proxy holder (one of the individuals
named on your proxy card) will vote your shares using his best judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Will any other business be conducted at the meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s bylaws require stockholders
to give advance notice of any proposal intended to be presented at the Special Meeting. We have not received any such notices.
Accordingly, the Company does not anticipate any additional business will be conducted at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How many votes are needed to approve
each proposal?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approval of all matters requires the favorable
vote of a majority of the votes cast on the applicable matter at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>How will abstentions be treated?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Abstentions will be treated as shares present
for quorum purposes and entitled to vote, and will have the same practical effect as votes against a proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What are &ldquo;broker non-votes&rdquo;?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broker non-votes occur when a beneficial
owner of shares held in &ldquo;street name&rdquo; does not give instructions to the broker or nominee holding the shares as to
how to vote on matters deemed &ldquo;non-routine.&rdquo; Generally, if shares are held in street name, the beneficial owner of
the shares is entitled to give voting instructions to the broker or nominee holding the shares. If the beneficial owner does not
provide voting instructions, the broker or nominee can still vote the shares with respect to matters that are considered to be
&ldquo;routine,&rdquo; but not with respect to &ldquo;non-routine&rdquo; matters. Under the rules and interpretations of the New
York Stock Exchange, &ldquo;non-routine&rdquo; matters include director elections (whether contested or uncontested) and matters
involving a contest or a matter that may substantially affect the rights or privileges of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the treatment of abstentions
and broker non-votes, the proposals at this meeting to (i) approve the issuance of shares of Common Stock to Esousa, (ii) approve
the exercise of warrants issued or issuable to Esousa to purchase up to an aggregate of 2,000,000 shares of Common Stock and (iii)
approve the conversion of&nbsp;a $1,000,000 Convertible Note convertible into 717,241 shares of Common Stock, are considered &ldquo;non-routine&rdquo;
matters, and brokers are not entitled to vote uninstructed shares with respect to these proposals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Who is paying for this proxy solicitation?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay for the
entire cost of soliciting proxies. In addition to these mailed proxy materials, our directors and employees may also solicit proxies
in person, by telephone or by other means of communication. The Board has engaged Kingsdale Advisors to assist in the solicitation
of proxies for a fee of $7,500, plus an additional per holder fee for any solicitation of individual holders and reimbursement
of out-of-pocket expenses. Directors and employees will not be paid any additional compensation for soliciting proxies but may
be reimbursed for out-of-pocket expenses incurred in connection with the solicitation. We will also reimburse brokerage firms,
banks and other agents for their reasonable out-of-pocket expenses incurred in forwarding proxy materials to beneficial owners.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>What does it mean if I receive more
than one set of proxy materials?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you receive more than one set of proxy
materials, your shares may be registered in more than one name or in different accounts. Please complete, sign and return each
proxy card to ensure that all of your shares are voted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>I share the same address with another
stockholder of the Company. Why has our household only received one set of proxy materials?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rules of the Securities and Exchange
Commission&rsquo;s (&ldquo;<B>SEC</B>&rdquo;) permit us to deliver a single set of proxy materials to one address shared by two
or more of our stockholders. This practice, known as &ldquo;householding,&rdquo; is intended to reduce the Company&rsquo;s printing
and postage costs. We have delivered only one set of proxy materials to stockholders who hold their shares through a bank, broker
or other holder of record and share a single address, unless we received contrary instructions from any stockholder at that address.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How can I find out the results of the
voting at the Special Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Final voting results will be disclosed
in a Form 8-K filed after the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Who can help answer my questions?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You can contact our corporate headquarters,
at DPW Holdings, Inc., 201 Shipyard Way, Newport Beach, CA 92663, by sending a letter to Milton C. &ldquo;Todd&rdquo; Ault, III,
our Chief Executive Officer, with any questions about the proposals described in this Proxy Statement or how to execute your vote.
In addition, you can also contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Kingsdale Advisors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Telephone (toll-free in North America):
(866) 851-2638</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Telephone (outside of North America): (416)
867-2272</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">E-mail: contactus@kingsdaleadvisors.com</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL NO. 1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>APPROVAL, PURSUANT TO NYSE AMERICAN
LISTING RULE 713, OF THE ISSUANCE OF SHARES OF OUR COMMON STOCK TO ESOUSA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are asking our stockholders to approve
the issuance of up to 26,637,684 shares of our Common Stock to Esousa pursuant to, and upon the terms and subject to the conditions
set forth in, the Master Exchange Agreement, dated February 10, 2020 (the &ldquo;<B>Exchange Agreement</B>&rdquo;), between the
Company and Esousa, an entity that acquired approximately $4.2 million dollars in principal amount, plus accrued but unpaid interest,
of certain promissory notes that had been previously issued by the Company to Dominion Capital, LLC, a Connecticut limited liability
company (the &ldquo;<B>Dominion Note</B>&rdquo;), and the Canadian Special Opportunity Fund, LP (the &ldquo;<B>CSOF Note</B>&rdquo;
and with the Dominion Note, the &ldquo;<B>Purchased Notes</B>&rdquo;) in separate transactions. Esousa also agreed to purchase
additional notes up to an additional principal amount, plus accrued but unpaid interest, of $3.5 million (the &ldquo;<B>Additional
Notes</B>&rdquo; and collectively, with the Purchased Notes, the &ldquo;<B>Notes</B>&rdquo;), prior to the second pricing period
discussed below (the &ldquo;<B>Second Purchase</B>&rdquo;). Pursuant to the Exchange Agreement, Esousa has the unilateral right
to acquire, among other things set forth therein, shares of the Company&rsquo;s Common Stock (the &ldquo;<B>Exchange Shares</B>&rdquo;)
in exchange for the Notes, which Notes evidence an aggregate of up to approximately $7.7 million of indebtedness of the Company.
The Exchange Agreement also provides that we may issue shares to Esousa to the extent that after giving effect to such issuance,
Esousa would not beneficially own in excess of a maximum percentage of 4.99% of the Common Stock (the &ldquo;<B>Maximum Percentage</B>&rdquo;),
as such Maximum Percentage may be adjusted. In addition, we may not issue additional shares to Esousa which would exceed 19.9%
of the total number of shares of Common Stock outstanding as of the date of the Exchange Agreement (or 861,580 shares) unless we
have obtained stockholder approval of the issuance of more than such number of shares in exchange for the Additional Notes, as
required by Rule 713(a)(ii) of the NYSE Company Guide, and subsequently, authorization from the NYSE American (together, the &ldquo;<B>Required
Approvals</B>&rdquo;). Esousa also received warrants to purchase 1,832,597 shares of Common Stock (the &ldquo;<B>Purchase Warrant</B>&rdquo;)
at an exercise price equal to $1.43 per share of Common Stock, and the exercise of the Warrant is also subject to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are seeking stockholder approval for
the issuance of shares in excess of 19.9% of the total number of shares of Common Stock outstanding as of the date of the Exchange
Agreement. If this Proposal is not approved by our stockholders, the Company will not be able to issue additional shares to Esousa
under the Exchange Agreement, and the Company anticipates it would need to seek alternative methods of repaying the promissory
notes underlying the Exchange Agreement, which may include additional transactions with Esousa. Ault &amp; Company, Inc. whose
Chief Executive Officer is Milton C. Ault, the Company&rsquo;s Chief Executive Officer and Chairman of the Board, has entered into
a voting agreement with Esousa pursuant to which it has agreed to vote its shares in favor of this Proposal 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview of Exchange Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 10, 2020, the Company entered
into the Exchange Agreement with Esousa. Pursuant to the Exchange Agreement, Esousa has the unilateral right to acquire the Exchange
Shares. Subsequent to the effective date of the Exchange Agreement, Esousa exchanged a portion of the Dominion Note for a limited
number of Exchange Shares (the &ldquo;<B>Initial Exchange</B>&rdquo;), and the second exchange (the &ldquo;<B>Second Exchange</B>&rdquo;
and together with the Initial Exchange, the &ldquo;<B>Exchange</B>&rdquo;) shall occur if, within sixty days after the Initial
Exchange, the Company receives the Required Approvals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement provides for two
pricing periods (each a &ldquo;<B>Pricing Period</B>&rdquo;), the first of which shall commence after the date on which Esousa
receives the Exchange Shares pursuant to the Initial Exchange and ending on the date that is 90 days after such receipt thereof,
subject to extension as provided for in the Exchange Agreement, and the second of which shall commence on the date on which Esousa
receives the Exchange Shares pursuant to the Second Exchange and ending on the date that is 90 days after such receipt thereof,
in either case, unless earlier terminated by Esousa by written notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During each pricing period, Esousa will
have the unilateral right to exchange the Notes for shares of the Company&rsquo;s Common Stock, or the Exchange Shares. The number
of shares to be issued upon each Exchange will be equal to (x) the principal and accrued but unpaid interest due on the Notes being
exchanged multiplied by 1.35, divided by (y) the closing bid price effective on each date of an exchange notice pursuant to Section
3(a)(9) of the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), provided, however, that the Company
shall theretofore have obtained the Required Approvals (the &ldquo;<B>Exchange Price</B>&rdquo;). The total number of shares of
the Company&rsquo;s Common Stock to be issued to Esousa in connection with the applicable Exchange shall be adjusted on the business
day immediately following the Pricing Period based upon the volume weighted average price (&ldquo;<B>VWAP</B>&rdquo;) of the Company&rsquo;s
Common Stock over the applicable Pricing Period (the &ldquo;<B>VWAP Shares</B>&rdquo;). VWAP Shares means the number of shares
determined by dividing (x) the Exchange Amount of the applicable Exchange, multiplied by 1.1, by (y) the greater of (I) seventy-five
percent (75.0%) of the VWAP of the Company&rsquo;s Common Stock over the applicable Pricing Period, or (II) $0.30 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the Initial Exchange, Esousa
acquired the Purchased Notes under the Exchange Agreement in exchange for approximately $4.2 million. The Second Exchange for the
remaining Notes in the approximate amount of $3.5 million will occur promptly following obtaining the Required Approvals. If our
stockholders do not approve this Proposal 1, neither the second Pricing Period nor the Second Exchange will occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Esousa does not have the right to exchange
Notes for shares of our Common Stock to the extent that following such exchange Esousa would beneficially own in excess of 4.9%
of our Common Stock, of the Maximum Percentage, as determined in accordance with Section 13(d) of the Securities Exchange Act of
1934, as amended. In addition, under no circumstances may the aggregate number of shares of Common Stock issued to Esousa in connection
with the exchange of the Notes at any time exceed 861,580 shares, which is equal to 19.9% of the total number of shares of our
Common Stock outstanding as of the date of the Exchange Agreement, unless we have obtained stockholder approval of the issuance
of more than such number of shares pursuant to Rule 713 of the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Exchange Agreement,
the Company also issued to Esousa the Purchase Warrant to purchase shares of the Company&rsquo;s Common Stock equal to (i) the
amount of the Additional Notes, multiplied by 0.83, and divided by (ii) the closing bid price of the Company&rsquo;s Common Stock
as of the date immediately prior to the Initial Exchange, or $1.30. The Purchase Warrant shall be exercisable, commencing on the
date upon which the Company&rsquo;s receives the Required Approvals thereof, for the exercise price of one hundred ten percent
(110%) of the closing bid price of the Company&rsquo;s Common Stock as of the date immediately prior to the Initial Exchange, or
$1.43. In connection therewith, the Company has agreed to file a registration statement to register the sale of the shares of Common
Stock underlying the exercise of the Purchase Warrant by Esousa pursuant to the Exchange Agreement. In the event that Esousa does
not purchase all of the Additional Notes, the Company shall have the option to acquire a portion of the Purchase Warrants from
Esousa for an aggregate price of $1.00. The Purchase Warrant may be exercised for cash. Upon the failure by the Company to maintain
an effective registration statement as set forth in the Exchange Agreement, the Company shall incur penalties for each month that
the SEC fails to declare such registration statement effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares issued under the Exchange Agreement
have been or will be issued pursuant to the exemption from registration set forth in Section 3(a)(9) of the Securities Act, which
permits an issuer to exchange new securities for existing securities exclusively where no commission or other remuneration is paid
or given directly or indirectly for soliciting such exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement contains customary
representations, warranties and covenants by the parties. Among other covenants, neither the Company nor any of its subsidiaries
may, directly or indirectly, issue any equity security or any equity-linked or related security until 30 days after the date of
the Second Exchange. In the event there is no Second Exchange, such restriction shall lapse 30 days after the end of the Pricing
Period applicable to the Initial Exchange. Moreover, during the period commencing on the date of the Exchange Agreement and ending
on the later of (i) 10 calendar days after the end of the Pricing Period or (ii) such time as when all of the Notes have been exchanged
or repaid, the Company may not directly or indirectly issue equity or debt securities of the Company to a party in exchange for
outstanding equity or debt securities in one or more transactions carried out pursuant to Section 3(a)(9) or Section 3(a)(10) of
the Securities Act, unless the Company has received prior written consent from Esousa. In addition, the Company has agreed to indemnify
Esousa and its affiliates for material misstatements or breaches of its obligations under the Exchange Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the Exchange Agreement is attached
as Exhibit 10.1 to the Company&rsquo;s Current Report on Form 8-K filed with the SEC on February 10, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Stockholder Approval Requirement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted above, the Exchange Agreement
provides that&nbsp;the number of shares to be issued to Esousa is initially limited to 19.9% of the total number of shares of Common
Stock outstanding as of the date of the Exchange Agreement until such time as the stockholders of the Company approve the issuance
of additional shares, which include the shares underlying the Purchase Warrant. We have agreed to promptly seek such stockholder
approval and are seeking such approval at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rule 713 of the NYSE American requires
stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer
of Common Stock (or securities convertible into or exercisable for Common Stock) at a price less than the greater of book or market
value which together with sales by officers, directors or principal stockholders of the issuer equals 20% or more of presently
outstanding Common Stock, or equal to 20% or more of presently outstanding stock for less than the greater of book or market value
of the stock, or when the issuance or potential issuance of additional shares will result in a change of control of the issuer.
Stockholder approval of this Proposal 1 will constitute stockholder approval for purposes of Rule 713 of the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are seeking stockholder approval for
the issuance of&nbsp;up to 26,637,684 shares of our Common Stock to Esousa in connection with the exchange of the Notes and the
exercise of the Purchase Warrant. We will seek additional stockholder approval before issuing shares in excess of that number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If our stockholders do not approve this
Proposal, the Company will need to find alternative means of refinancing or extending the Notes, and the Company may not be successful
in such efforts. If the Company is unable to refinance or extend the Notes, the Company may default on the Notes, which would materially
adversely affect the Company and could result in severe curtailment of the Company&rsquo;s activities and the insolvency of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our stockholders are not entitled to dissenters&rsquo;
rights with respect to this Proposal, and we will not independently provide stockholders with any such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Reasons for Transaction</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After considering various alternative transactions,
including potential capital raises and extensions of or refinancing the Notes, the Board of Directors determined that the Exchange
Agreement with Esousa is in the best interests of the Company and its stockholders because it permits the Company to issue equity
in exchange for the $7,700,000 due under the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement eliminates debt
in which the Company was in default and the Company believes the impact of the Exchange Agreement should also improve the Company&rsquo;s
financial results by reducing the Company&rsquo;s borrowing costs and enabling management to focus on growing the Company&rsquo;s
business, which was challenging in light of the constraints under the Company&rsquo;s prior debt agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Effect on Current Stockholders; Dilution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement does not affect
the rights of the holders of outstanding Common Stock, but the issuance of shares to Esousa pursuant to&nbsp;the&nbsp;terms of
the Exchange Agreement will have a dilutive effect on our existing stockholders, including the voting power and the economic rights
of the existing stockholders. If we were to have issued Esousa all 861,580 shares which it may acquire absent stockholder approval,
Esousa would have acquired approximately&nbsp;16.03% of the 5,375,085 shares that would then have been outstanding as of the Record
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The availability for sale of a large amount
of shares by Esousa may depress the market price of our Common Stock and, going forward, may impair our ability to raise additional
capital through the public sale of our Common Stock. We do not have any arrangement with Esousa to address the possible effect
on the price of our Common Stock of the sale by Esousa of its shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted above, the Exchange Agreement
provides that the Company shall not issue, and Esousa shall not acquire, any shares of our Common Stock under the Exchange Agreement
if such shares proposed to be issued and sold, when aggregated with all other shares of our Common Stock then owned beneficially
(as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended) by Esousa and its affiliates, would
result in the beneficial ownership by Esousa and its affiliates in excess of the Maximum Percentage. This beneficial ownership
limitation limits the number of shares Esousa may beneficially own at any one time to 4.9% of our outstanding Common Stock. Consequently,
the number of shares Esousa may beneficially own in compliance with the beneficial ownership limitation may increase over time
as the number of outstanding shares of our Common Stock increases over time. Esousa may sell some or all of the shares it acquires
under the Exchange Agreement, subject to Esousa&rsquo;s compliance with the Securities Act and applicable state law. Even though
Esousa&rsquo;s beneficial ownership of our Common Stock is subject to the Maximum Percentage, Esousa may be in a position to exert
influence over the Company and there is no guarantee that the interests of Esousa will align with the interests of other stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Required Vote
and Board Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance of shares to Esousa requires
the receipt of the affirmative vote of a majority of the shares of the Company&rsquo;s Common Stock present in person or by proxy
and voting at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Board unanimously recommends a vote
&ldquo;FOR&rdquo; the approval of the issuance of shares of Common Stock to Esousa in order to comply with Rule 713 of the NYSE
American.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL NO. 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPROVAL OF THE EXERCISE OF WARRANTS
TO PURCHASE UP TO 2,000,000 SHARES OF COMMON STOCK IN ORDER TO&nbsp;COMPLY WITH&nbsp;RULE 713 OF THE NYSE AMERICAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Terms of the Transaction</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may issue one or more 12% Secured
Promissory Term Notes (the &ldquo;<B>Esousa Notes</B>&rdquo;) to Esousa Holdings, LLC (&ldquo;<B>Esousa</B>&rdquo;) before the
date of the Special Meeting in an aggregate amount of up to $2,000,000 and will in no event issue any such notes beyond June 29,
2020, which is 90 days from the date of the Special Meeting. In connection with issuance any such Esousa Notes, the Company has
agreed to issue Esousa warrants to purchase that number of shares of Common Stock equal to the principal amount of the aggregate
amount of the Esousa Notes divided by the closing market price of the shares of Common Stock on the date that a particular Esousa
Note was purchased, subject to a floor of $1.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Description of the Warrants </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Esousa will in connection with the purchase
of the Esousa Notes be issued the warrants described above (the &ldquo;<B>Esousa Warrants</B>&rdquo;) to purchase that number of
shares of Common Stock equal to the principal amount of the aggregate amount of the Esousa Notes divided by the closing market
price of the shares of Common Stock on the date that a particular Esousa Note was purchased, subject to a floor of $1.00. The Esousa
Warrants will be exercisable at a price equal to 110% of the closing market price of the shares of Common Stock on the date that
a particular Esousa Note was purchased and be exercisable for a period of five years from their issuance date. The exercise price
of the Esousa Warrants shall be subject to adjustment for customary stock splits, stock dividends, combinations or similar events.
The Company intend to use any proceeds it may receive from the exercise of the Esousa Warrants for general working capital purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Why the Company Needs Stockholder Approval</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rule 713 of the NYSE&nbsp;American requires
stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer
of Common Stock (or securities convertible into or exercisable for Common Stock) at a price less than the greater of book or market
value which together with sales by officers, directors or principal stockholders of the issuer equals 20% or more of presently
outstanding Common Stock, or equal to 20% or more of presently outstanding stock for less than the greater of book or market value
of the stock, or when the issuance or potential issuance of additional shares will result in a change of control of the issuer.
The exercise price of the Esousa Warrants will be lower than the market price of our Common Stock on the issuance dates of the
Esousa Notes and may be lower than the market price upon exercise. Accordingly, Esousa is prohibited from exercising the Esousa
Warrants and receiving shares of our Common Stock unless stockholder approval is obtained for the Esousa Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Effect of Proposal on Current Stockholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Proposal No.&nbsp;2 is adopted,
up to 2,000,000 shares of Common Stock would be issuable. Based on the number of shares of Common Stock outstanding as of the Record
Date, such shares would represent 28.80% of our total outstanding shares (giving effect to such issuance). The issuance of such
shares may result in significant dilution to our stockholders and afford them a smaller percentage interest in the voting power,
liquidation value and aggregate book value of the Company. The sale or any resale of the Common Stock issued upon exercise of the
Esousa Warrants could cause the market price of our Common Stock to decline as well as result in substantial dilution to other
stockholders since Esousa may ultimately exercise and sell the full amount issuable on exercise. This means that our current stockholders
will own a smaller interest in our Company and will have less ability to influence significant corporate decisions requiring stockholder
approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Required Vote and Board Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise of the Esousa Warrants requires
the receipt of the affirmative vote of a majority of the shares of the Company&rsquo;s Common Stock present in person or by proxy
and voting at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Board unanimously recommends a vote
&ldquo;FOR&rdquo; the approval issuance of Common Stock upon of the exercise the Esousa Warrants for up to 2,000,000 shares of
Common Stock in order to&nbsp;comply with&nbsp;Rule 713 of the NYSE American.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL NO. 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPROVAL OF THE CONVERSION OF A $1,000,000
CONVERTIBLE PROMISSORY NOTE INTO 717,241 SHARES OF COMMON STOCK IN ORDER TO&nbsp;COMPLY WITH&nbsp;RULE 713 OF THE NYSE AMERICAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Terms of the Transaction</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 5, 2020, we sold an 8% Convertible
Promissory Note (the &ldquo;<B>Ault Note</B>&rdquo;) to Ault &amp; Company. As described further below, the principal of the Ault
Note may be converted into shares of Common Stock at a conversion price of $1.45 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Ault Note is in the principal amount
of $1,000,000 and was sold for $1,000,000, bears interest at 8% simple interest on the principal amount, and is due on August 5,
2020 (the &ldquo;<B>Maturity Date</B>&rdquo;). The principal and accrued interest thereon may be converted into our shares of&nbsp;Common
Stock at $1.45 per share. Commencing on the date that the approval of the Company&rsquo;s stockholders of this Proposal is obtained,
as required by Rule 713(a)(ii) of the NYSE Company Guide, Ault &amp; Company may convert the principal amount of the Ault Note
at any time into Common Stock. The conversion price of the Ault Note is subject to adjustment for customary stock splits, stock
dividends, combinations or similar events. Assuming the Ault Note is converted into shares of Common Stock on the Maturity Date,
we would issue to Ault &amp; Company a number of shares of Common Stock equal to $1,000,000 in principal plus interest of $40,000
divided by $1.45, or 717,241 such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Why the Company Needs Stockholder Approval</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rule 713 of the NYSE&nbsp;American requires
stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer
of Common Stock (or securities convertible into or exercisable for Common Stock) at a price less than the greater of book or market
value which together with sales by officers, directors or principal stockholders of the issuer equals 20% or more of presently
outstanding Common Stock, or equal to 20% or more of presently outstanding stock for less than the greater of book or market value
of the stock, or when the issuance or potential issuance of additional shares will result in a change of control of the issuer.
The initial conversion price of the Ault Note was equal to the market price of our Common Stock on the day immediately prior to
execution date of the Ault Note. Accordingly, Ault &amp; Company is prohibited from converting the Ault Note and receiving shares
of our Common Stock unless stockholder approval is obtained for the Ault Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Effect of Proposal on Current Stockholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Proposal No.&nbsp;3 is adopted,
based on the conversion of the Ault Note, up to 717,241 shares of Common Stock would be issuable. Based on the number of shares
of Common Stock outstanding as of the Record Date, such shares would represent 12.67% of our total outstanding shares (giving effect
to such issuance). The issuance of such shares may result in significant dilution to our stockholders and afford them a smaller
percentage interest in the voting power, liquidation value and aggregate book value of the Company. The sale or any resale of the
Common Stock issued upon conversion of the Ault Note could cause the market price of our Common Stock to decline as well as result
in substantial dilution to other stockholders since Ault &amp; Company may ultimately convert and sell the full amount issuable
on conversion and exercise. This means that our current stockholders will own a smaller interest in our Company and will have less
ability to influence significant corporate decisions requiring stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Further Information.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of the Ault Note are complex
and only briefly summarized above. For further information, please refer to the descriptions contained in the Company&rsquo;s Current
Report on Form 8-K filed with the SEC on February 6, 2020, and the transaction documents filed as exhibits to such report. The
discussion herein is qualified in its entirety by reference to such filed transaction documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Required Vote and Board Recommendation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The conversion of the Ault Note requires
the receipt of the affirmative vote of a majority of the shares of the Company&rsquo;s Common Stock present in person or by proxy
and voting at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Board unanimously recommends a vote
&ldquo;FOR&rdquo; the approval issuance of 717,241 shares of Common Stock upon of the conversion of the Ault Note in order to&nbsp;comply
with&nbsp;Rule 713 of the NYSE American.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain
information concerning the number of shares of our Common Stock beneficially owned based on 4,943,649 issued and outstanding shares
of Common Stock as of the Record Date by: (i) each of our directors; (ii) each of our named executive officers; and (iii) each
person known to us to be the beneficial owner of more than 5% of the outstanding shares of our Common Stock based upon Schedules
13G or 13D filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beneficial ownership is determined in accordance
with the rules of the SEC and generally includes voting or investment power with respect to securities. Other than as described
in the notes to the table, we believe that all persons named in the table have sole voting and investment power with respect to
shares beneficially owned by them. All share ownership figures include shares issuable upon exercise of options or warrants exercisable
within 60 days of the Record Date, which are deemed outstanding and beneficially owned by such person for purposes of computing
his or her percentage ownership, but not for purposes of computing the percentage ownership of any other person.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The address for each of the officers and
directors is c/o DPW Holdings, Inc., 201 Shipyard Way, Newport Beach, California 92663.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="border-bottom: black 1.5pt solid; white-space: nowrap"><B>Name and address of beneficial owner</B></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number of</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>shares</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>beneficially</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>owned</B></P></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Approximate</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Percent</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of class</B></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><B><U>Greater than 5% Beneficial Owners</U></B>:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>Ault &amp; Company, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right">674,911</TD>
    <TD STYLE="text-align: right"><SUP>(2)</SUP></TD>
    <TD STYLE="text-align: right">13.64%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><B><U>Directors and executive officers: <SUP>(1)</SUP></U></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD>Milton&nbsp;Ault, III</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right">674,954</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><SUP>(3)</SUP></TD>
    <TD STYLE="vertical-align: top; text-align: right">13.64%</TD></TR>
<TR STYLE="background-color: white">
    <TD>Henry Nisser</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right">3,906</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><SUP>(4)</SUP></TD>
    <TD STYLE="vertical-align: top; text-align: right">*</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD>Amos Kohn</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right">698</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><SUP>(5)</SUP></TD>
    <TD STYLE="vertical-align: top; text-align: right">*</TD></TR>
<TR STYLE="background-color: white">
    <TD>Robert Smith</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right">108</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><SUP>(6)</SUP></TD>
    <TD STYLE="vertical-align: top; text-align: right">*</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD>William Horne</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right">556</TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><SUP>(7)</SUP></TD>
    <TD STYLE="vertical-align: top; text-align: right">*</TD></TR>
<TR STYLE="background-color: white">
    <TD>Mordechai Rosenberg</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right">0</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">*</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD>Jeffrey A. Bentz</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; text-align: right">9</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: right">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>Jodi Brichan</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; text-align: right">0</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>All directors and executive officers as a group (eight persons)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; text-align: right">680,231</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right">13.75%</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3.95pt"></TD><TD STYLE="width: 18pt">*</TD><TD STYLE="text-align: justify">Less than one percent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Unless otherwise indicated, the business address of each of the individuals is c/o DPW Holdings,
Inc., 201 Shipyard Way, Suite E, Newport Beach, California 92663.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Includes shares owned by Philou Ventures of which Ault &amp; Company, Inc., is the Manager, consisting
of: (i) 125,000 shares of Series B Preferred Stock that are convertible into 2,232 shares of Common Stock, (ii) warrants to purchase
2,232 shares of Common Stock that are exercisable within 60 days of the Record Date and (iii) 3,408 shares of Common Stock. Also
includes warrants to purchase 94 shares of Common Stock that are exercisable within 60 days of the Record Date. Excludes 717,241
shares of Common Stock issuable upon conversion of the Ault Note.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">Mr. Ault is the Chief Executive Officer of Ault &amp; Company, Inc. Includes 674,911 shares beneficially
owned by Ault &amp; Company, which may be deemed beneficially owned by Mr. Ault. Also includes 43 shares of Common Stock. Excludes
717,241 shares of Common Stock issuable upon conversion of the Ault Note.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">Includes 3,906 shares of Common Stock issuable pursuant to a stock incentive grant.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(5)</TD><TD STYLE="text-align: justify">Includes warrants to purchase 505 shares of Common Stock that are exercisable within 60 days of
the Record Date.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(6)</TD><TD STYLE="text-align: justify">Includes warrants to purchase 54 shares of Common Stock that are exercisable within 60 days of
the Record Date.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(7)</TD><TD STYLE="text-align: justify">Includes 250 shares of Common Stock issuable pursuant to a stock incentive grant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OTHER BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board knows of no business to be brought
before the Special Meeting other than as set forth above. If other matters properly come before the stockholders at the Special
Meeting, it is the intention of the persons named on the proxy to vote the shares represented thereby on such matters in accordance
with their judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;/s/ </FONT><I>Milton C. Ault, III</I></TD>
    <TD STYLE="width: 80%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><I>Milton C. Ault, III</I></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><I>Chief Executive Officer and Chairman of the Board</I></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 11, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

      <IMG SRC="proxycard11.jpg"><P STYLE="margin: 0">&#160;</P>
    <!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt">
      <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt">
        <TR STYLE="vertical-align: top; text-align: left">
          <TD STYLE="width: 33%">&nbsp;</TD>
          <TD STYLE="width: 34%; text-align: center"></TD>
          <TD STYLE="width: 33%; text-align: right">&nbsp;</TD>
        </TR>
      </TABLE>
    </DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"></DIV>
    <!-- Field: /Page -->
  <P STYLE="margin: 0">&#160;</P><IMG SRC="proxycard12.jpg"><P STYLE="margin: 0">&#160;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 1pt; color: White">llllllllllllllllllllllllllllllllllllllllllllllllllllllllllll
I/A!!! TE Using a black Inlt pen, mark your votes with an X as shown in this example. X Please do not write outside the designated
areas. Special Meeting Proxy Card V IF VOTING BY MAIL, SIGN, DETACN AND RETURN TNE BOTTON PORTION IN THE ENCLOSED ENVELOPE V u
Proposals &mdash; The Board of Directors recommends a vote FOR Proposals 1, Z, 3 and 4. + I T H R I m Hh NYSE A _ tn For Against
Abstain 2 T th _ f t _ d _ bi t For Against Abstain . 0 approve, pursuan o u e o e merican, e . 0 approve e exercise 0 warran
s issue or issua e o issuance of shares of the Corporation's Class A common stock, U U U Esousa to purchase up to an aggregate
of 2,000,000 shares oi U U D par value $0.001 per share (&ldquo;Common Stock&quot;) to Esousa Common Stock, issued in connection
with certain term Holdings LLC (&rdquo;Esousa&quot;). in accordance with the Master promissory notes in an aggregate amount of
up to $2,000,000. Exchange Agreement dated February i0, 2020, and the exercise of warrants issued in connection therewith. 3.
To approve the conversion of a $l,000,000 Convertible 4. The transaction of such other business as may properly come Promissory
Note issued on February 5, Z020 (the &ldquo;Ault Note&quot;). U U U before the Special Meeting or any adjournments or U U U to
Ault &amp; Company, lnc., which is convertible into 717,241 shares postponements thereof. of Common Stock at $1.45 per share (which
figure presumes conversion of principal and accrued but unpaid interest as of August 5, Z020, the maturity date of the Ault Note),
in order to comply with the listing rules the NYSE American. u Authorized Signatures &mdash; This section must be completed for
your vote to be counted. &mdash; Date and Sign Below Please sign exactly as nameis) appears hereon. Joint owners should each Sign.
when signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title.
Date (mm/dd/VYYy) &mdash; Please print date below. Signature 1 &mdash; Please keep signature within the box. Signature 2 &mdash;
Please keep signature within the box. I 1UPX 455366 + D37SVB V IF VOTING BY NAIL, SIGN, DETACH AND RETURN TNE BOTTON PORTION IN
THE ENCLOSED ENVELOPE V Proxy &mdash; DPW HOLDINGS, INC. 201 Shipyard Way Newport Beach, CA 92663 (949) 444-5464 THIS PROXY IS
SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoints Milton &quot;Todd&quot; Ault, lll and William B.
Horne, or any one of them, as proxy, with full power to appoint substitutes, and hereby authorizes Messrs. Ault and Horne, or
any one of them, to represent and to vote as designated below, all the shares of common stock of DPW Holdings, lnc., held of record
by the undersigned as of March 2, Z020, at the 2020 Special Meeting of Stockholders to be held at the Hyatt Regency, Newport Beach,
located at 1107 Jamboree Road, Newport Beach, CA 92660, at 9 a.m. Pacific Time, on March 31, 2020, and any adjournments or postponements
thereof, and hereby ratifies all that said proxies may do by virtue hereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED
IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR THE PROXY
HOLDER WILL HAVE DISCRETIONARY AUTHORITY TO VOTE WITH RESPECT TO OTHER BUSINESS WHICH PROPERLY MAY COME BEFORE THE MEETING, OR
ANY ADJOURNMENTS OR POSTPONEMENTS THEREOF PLEASE READ, SIGN, DATE AND RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE.
THE UNDERSIGNED HEREBY ACKNOWLEDGES RECEIPT OF THE NOTICE OF SPECIAL MEETING AND PROXY STATEMENT FURNISHED IN CONNECTION THEREWITH.</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

      <IMG SRC="proxycard21.jpg"><P STYLE="margin: 0">&#160;</P>
    <!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt">
      <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt">
        <TR STYLE="vertical-align: top; text-align: left">
          <TD STYLE="width: 33%">&nbsp;</TD>
          <TD STYLE="width: 34%; text-align: center"></TD>
          <TD STYLE="width: 33%; text-align: right">&nbsp;</TD>
        </TR>
      </TABLE>
    </DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"></DIV>
    <!-- Field: /Page -->
  <P STYLE="margin: 0">&#160;</P><IMG SRC="proxycard22.jpg"><P STYLE="margin: 0">&#160;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 1pt; color: White">I/A!!! TE III III
III III I] Ll ENDORSEMENLLINE ____ ___ sAcxPAck__ ||mi|||||||l||||||||i||||||[ill|||||||||i||||]||||i|||l||||i|||&quot;|||||||||1|||i||i|||l
MR ASAMPLE DESIGNATION ADD i ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 (IF ANY) lll||I|IllllIllllIllll||||||||||Illll||||I|||l||||||||||||l|
ll||||||||||||||l|||||||l|||||||Illll||||||||||||||||||||I|||l|||||||l|| c12s45e7s9 0O00000O0.000000 ext O00O00O00.000000 ext
000000000.000000 ext O00000000.000000 ext OOOOOOOOOOOOOOO ext 000000000000000 ext Your vote matters - here's how to vote! You
may vote online or by phone instead of mailing this card. Votes submitted electronically must be received by 11:59 p.m, Eastern
Time, on &mdash; March 30, Z020. . 0 l' EL; E&lsquo; n me H3, &rsquo; Go to www.envisionreports.com/DPW or E ' , scan the 0R code
&mdash; login details are ' &quot; '1 located in the shaded bar below. Phone Call toll free 1-800-652-VOTE (8683) within the USA,
US territories and Canada Save paper, time and money! Usillll a black Ink Den, mark your votes with an X as shown in this example.
Slqn up electron&quot;: dellvery at Please do not write outside the designated areas. WWW.enVlSlOI'lF&euro;p0l'tS.C0m/ Special
Meeting Proxy Card ( 1234 5678 9012 345 &gt; V IF VOTING BY MAIL, SIGN, DETACN AND RETURN TNE BOTTON PORTION IN THE ENCLOSED ENVELOPE.
V u Proposals &mdash; The Board of Directors recommends a vote FOR Proposals 1, Z, 3 and 4. + For Against Abstain For Against
Abstain 1. To approve, pursuant to Rule 713 of the NYSE American, the 2. To approve the exercise of warrants issued or issuable
to issuance of shares of the Corporation's Class A common stock, U U U Esousa to purchase up to an aggregate of 2,000,000 shares
of U U U par value $0.001 per share (&ldquo;Common Stock&quot;) to Esousa Common Stock, issued in connection with certain term
Holdings LLC (&rdquo;Esousa&quot;). in accordance with the Master promissory notes in an aggregate amount of up to $2,000,000.
Exchange Agreement dated February 10, 2020, and the exercise of warrants issued in connection therewith. 3. To approve the conversion
of a $1,000,000 Convertible 4. The transaction of such other business as may properly come Promissory Note issued on February
5, Z020 (the &ldquo;Ault Note&quot;), U U '3 before the Special Meeting or any adjournments or U U U to Ault &amp; Company, Inc.,
which is convertible into 717,241 shares postponements thereof. of Common Stock at $1.45 per share (which figure presumes conversion
of principal and accrued but unpaid interest as of August 5, Z020, the maturity date of the Ault Note). in order to comply with
the listing rules the NYSE American. u Authorized Signatures &mdash; This section must be completed for your vote to be counted.
&mdash; Date and Sign Below Please sign exactly as namets) appears hereon. Joint owners should each sign. when signing as attorney,
executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title Date (mm/dd/VYYy) &mdash;
Please print date below. Signature I &mdash; Please keep signature within the box. Signature 2 &mdash; Please keep signature within
the box. MR A SAMPLE ITHS AREA IS SET UP TO ACCOMMODATE C J N T '40 Ct~ARAC'ERS/MRASAMPLE /\NDt.lRASAlvlPLE AND MR A SAMPLE AND
MR A 5AlulPLE Al\D MR A SAMPLE AND - 1 U P X 4 5 5 3 6 6 I/IRASAMPLE ANDl\'lR&lsquo;A$AMPLE AND ll/IRASAMPLE AND + 0375113 Small
steps make an impact. Help the environment by consenting to receive electronic delivery. sign up at www.envisionreports.com/DPW
V |r VOTING BY MAIL, SIGN, DEIACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE V Proxy &mdash; DPW HOLDINGS, INC. +
201 Shipyard Way Newport Beach, CA 92663 (949) 444-5464 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned
hereby appoints Milton &quot;Todd&quot; Ault, III and William B. Horne, or any one of them, as proxy, with full power to appoint
substitutes, and hereby authorizes Messrs. Ault and Horne, or any one of them, to represent and to vote as designated below, all
the shares of common stock of DPW Holdings, Inc., held of record by the undersigned as of March 2, Z020, at the 2020 Special Meeting
of Stockholders to be held at the Hyatt Regency, Newport Beach, located at I107 Jamboree Road, Newport Beach, CA 92660, at 9 a.m.
Pacific Time, on March 31, 2020, and any adjournments or postponements thereof, and hereby ratifies all that said proxies may
do by virtue hereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER.
IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR THE PROXY HOLDER WILL HAVE DISCRETIONARY AUTHORITY TO VOTE WITH RESPECT
TO OTHER BUSINESS WHICH PROPERLY MAY COME BEFORE THE MEETING, OR ANY ADJOURNMENTS OR POSTPONEMENTS THEREOF PLEASE READ, SIGN,
DATE AND RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE. (IF YOU VOTE BY INTERNET, PLEASE DO NOT MAILBACK THIS PROXY CARD).
THE UNDERSIGNED HEREBY ACKNOWLEDGES RECEIPT OF THE NOTICE OF SPECIAL MEETING AND PROXY STATEMENT FURNISHED IN CONNECTION THEREWITH.
H Non-Voting Items Change oi Address - Please print new address below. I +</FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
